A California congresswoman plans to hold a hearing in about a month to explore the national-security risks posed by China’s dominance of the U.S. pharmaceutical supply chain, escalating concerns raised by the Pentagon.
Global health regulators sounded a coordinated alarm about the possibility that a stomach drug taken by millions of people could be tainted with the same cancer-causing agent that has sparked a worldwide recall of blood-pressure pills.
U.S. manufacturers are lagging their European counterparts in the adoption of creative approaches to supply-chain finance. But three companies are demonstrating the varied ways in which that tool can be effectively deployed.
Deep under gum-tree lined paddocks in southern Australia that delivered a bullion bonanza in the 19th Century, the unexpected promise of a second gold rush is luring a new generation of prospectors from billionaires to global miners and weekend panhandlers.
Wednesday, October 30, 2019 12:00 to Thursday, January 30, 2020 12:00
DATE: Wednesday, October 30, 2019 TIME: 1:00 PM CT
Today’s Procurement leaders are challenged when it comes to associating people with businesses. To understand the risk involved with any given organization, it’s critical to have a view into the Ultimate Beneficial Ownership (UBO).
Researching and documenting the full ownership of your suppliers can be a manual and time consuming process. Dun & Bradstreet, the trusted source of insight on B2B relationships and corporate hierarchies understands the challenge to get deeper understanding of business ownership.
Join us for this free webinar to learn about:
The evolution of UBO
Current strategies in screening and onboarding
Various use cases for a better understanding of UBO relationships.